more_reports

Pulmatrix Inc.

PULM:NASDAQ

Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE technology.

streetwise book logo Streetwise Company Fact Sheet

2025/8/5 5:04:48

(PULM:NASDAQ)